ECJ (Advocate General’s Opinion) – Directive 98/44/EC – Legal protection of biotechnological inventions – Patentability – Stem cells – Stimulation by parthenogenesis of unfertilised human ova to create stem cells – Parthenotes – List of inventions excluded from patentability – Non-exhaustive character of the list – Exclusion of ‘uses of human embryos for industrial or commercial purposes’ – Notion of ‘human embryo’ – ‘Capable of commencing the process of development of a human being’
Cruz Villalon AG
C-364/13, [2014] EUECJ C-364/13 – O, CLI:EU:C:2014:2104
Bailii
Directive 98/44/EC
European
Citing:
At IPO – International Stem Cell Corporation (Patent) IPO 16-Aug-2012
IPO Patent applications GB0621068.6 and GB0621069.4 relate to methods where parthenogenesis is used to activate a human oocyte (i.e. stimulation of a human oocyte, without fertilisation by a sperm cell) to . .
Reference – International Stem Cell Corporation v Comptroller General of Patents ChD 17-Apr-2013
The company appealed against refusal of patentunder the provision restricting such for ‘uses of human embryos for industrial or commercial purposes’
Held: The matter was referred to the ECJ. . .
Cited by:
Opinion – International Stem Cell Corporation v Comptroller General of Patents ECJ 18-Dec-2014
ECJ Grand Chamber – Reference for a preliminary ruling – Directive 98/44/EC – Article 6(2)(c) – Legal protection of biotechnological inventions – Parthenogenetic activation of oocytes – Production of human . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 17 December 2021; Ref: scu.534448